Page 167 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix C. Appendix Tables for Key Questions 1–4

a
Appendix Table C1.1. Descriptive characteristics of the epidemiologic studies considered relevant to KQ1
Author Database Start End Sample size Eligibility criteria
Year year year
uid
16
Mebane SEER, TNCS 1969 1985 NR Data presented only for Black and White individuals.
1990
2258952
SEER, NCHS 1969 1995 229,556 Invasive prostate cancer cases, excluding histology codes for lymphoma and
17
Hankey [prostate cancer patients of unknown ethnicity. Data were available for 1968-95 for mortality
1999 cases in SEER, and 1973-95 for incidence rates.
10379964 1975-95]
18
Chu SEER, NCHS 1969 1999 NR Men with a first primary prostate cancer. Data were available from 1969-99
2003 for mortality and 1975-99 for incidence rates.
12627516
19
Brawley SEER 1973 1994 NR NR
1997
9351560
20
Merrill SEER 1973 1992 NR NR
1997
9229202
78
Smart SEER 1973 1993 208,234 NR
1997
9351557
21
Farkas SEER 1973 1994 156,598 White and African-American prostate cancer patients
1998
9730458
22
Perrotti SEER 1973 1994 224,595 Excluded patients with tumors of anaplastic or transitional cell histology. Two
1998 groups of patients based on year of diagnosis (1980-84 and 1990-94) were
9720554 assessed to reflect patterns of cancer presentation before and after the
introduction of early detection methods (PSA and trans-rectal ultrasound
guided biopsies).
79
Merrill SEER 1973 1993 81,497 NR
1999 [cancers diagnosed
10522656 between 1986 and
1993; data not
reported for other
years]

a Pre-1980 data were not extracted for this review; however, in this table we have extracted information on the first and last year covered by each eligible study.

C-1